MTND1P4

Across TCGA pan-cancer cohorts, MTND1P4 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MTND1P4 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MTND1P4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND1P4 expression acts as an unfavorable survival marker.

THCA, STAD, and HNSC are the cancer types where MTND1P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	IV	0.252	1.000	<.001	57	view →
STAD	OS	Tertile	IV	0.115	0.648	<.001	55	view →
HNSC	OS	Tertile	II,III,IV	0.082	0.711	<.001	54	view →
UVM	DFS	Tertile	All	0.071	0.746	<.001	54	view →
SKCM	DFS	Tertile	All	0.398	0.623	.004	21	view →
UCS	DFS	Tertile	IV	0.318	0.745	.042	18	view →
CESC	OS	Tertile	II,III,IV	0.132	0.555	.043	12	view →
LIHC	DFS	Tertile	III,IV	0.077	0.414	.004	9	view →
TGCT	OS	Median	All	0.918	1.000	.034	4	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MTND1P4–THCA (OS)

Open the THCA breakdown →